AIDS Alert Archives – July 1, 2003
July 1, 2003
View Archives Issues
-
ADAP woes deepen as budgets worsen and longevity improves
Ever since the AIDS Drug Assistance Program (ADAP) faced the challenge of funding highly active antiretroviral treatment (HAART) in the late 1990s, there have been annual funding problems that resulted in some states capping enrollment, restricting drug formularies, and putting some HIV-positive clients on waiting lists. -
Assumptions are made in new ADAP plan
Here are assumptions the Washington, DC-based ADAP Working Group used to make its funding projects for the coming year: -
States handle shortfall in a variety of ways
States across the nation are gearing up for a cold fall and winter when it comes to funding for the AIDS Drugs Assistance Programs (ADAPs). -
On-line dating: Is it a new ‘computer virus’?
A recent study shows a link between very high-risk sexual behavior and meeting sex partners on-line, according to New York researchers. -
Research shows a need for post-exposure advice
A San Francisco study of a telephone hotline for people who may have been exposed to HIV through nonoccupational risk behavior shows that there is a reasonable demand for post-exposure prophylaxis (PEP). -
Studies link HIV drugs and bone density problems
Several recent studies add to the evidence that HIV infection and possibly highly active antiretroviral treatment (HAART) increase risks or at least are associated with the loss of bone mass among women and children. -
FDA Notifications
New dosing option approved for Viracept; Labeling rule proposed for dietary supplements; FDA completes first phase of Drugs@FDA -
Journal Review
The public health response to severe acute respiratory syndrome (SARS) has been strikingly rapid on many fronts, but a global pandemic of a new infectious disease still is a real possibility, the author warned.